Bio-Techne Corp
NASDAQ:TECH

Watchlist Manager
Bio-Techne Corp Logo
Bio-Techne Corp
NASDAQ:TECH
Watchlist
Price: 53.6 USD -0.26% Market Closed
Market Cap: 8.4B USD

Intrinsic Value

The intrinsic value of one TECH stock under the Base Case scenario is 50.32 USD. Compared to the current market price of 53.6 USD, Bio-Techne Corp is Overvalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TECH Intrinsic Value
50.32 USD
Overvaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Bio-Techne Corp

What is Valuation History?
Compare TECH to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Academic and pharma research spending cuts could significantly reduce demand for Bio-Techne’s core reagent and assay products, exacerbating top-line pressure given its sizable exposure to these often cyclical customer segments.

Bull Theses

Its extensive catalog of specialized reagents, assays, and instruments positions Bio-Techne to capitalize on accelerating interest in high-growth areas such as precision medicine and gene therapy research.

Show More Less
How do you feel about TECH?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Bio-Techne Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bio-Techne Corp

Current Assets 627.2m
Cash & Short-Term Investments 140.7m
Receivables 237.1m
Other Current Assets 249.4m
Non-Current Assets 2B
Long-Term Investments 254.5m
PP&E 335.7m
Intangibles 1.4B
Other Non-Current Assets 14.5m
Efficiency

Free Cash Flow Analysis
Bio-Techne Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Bio-Techne Corp

Revenue
1.2B USD
Cost of Revenue
-406.2m USD
Gross Profit
802.5m USD
Operating Expenses
-584.3m USD
Operating Income
218.2m USD
Other Expenses
-86.6m USD
Net Income
131.6m USD
Fundamental Scores

TECH Profitability Score
Profitability Due Diligence

Bio-Techne Corp's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Healthy Operating Margin
51/100
Profitability
Score

Bio-Techne Corp's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

TECH Solvency Score
Solvency Due Diligence

Bio-Techne Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
Low D/E
81/100
Solvency
Score

Bio-Techne Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TECH Price Targets Summary
Bio-Techne Corp

Wall Street analysts forecast TECH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TECH is 68.1 USD with a low forecast of 55.55 USD and a high forecast of 87.15 USD.

Lowest
Price Target
55.55 USD
4% Upside
Average
Price Target
68.1 USD
27% Upside
Highest
Price Target
87.15 USD
63% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Aug 17, 2025
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for TECH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TECH Insider Trading
Buy and sell transactions by insiders

TECH News

Other Videos
What is the Intrinsic Value of one TECH stock?

The intrinsic value of one TECH stock under the Base Case scenario is 50.32 USD.

Is TECH stock undervalued or overvalued?

Compared to the current market price of 53.6 USD, Bio-Techne Corp is Overvalued by 6%.

Back to Top